Anyone tried Votrient (pazopanib)?

Hello....my Wife has been on Votrient 13 months. It has helped in her situation with leiomyosarcoma. Each patient will have different reactions to Votrient and different outcomes. The best aspect of this medication is it's not chemo!! There are possible impacts on liver function. Most patients report manageble side effects. One important step that may help is to start on a low dose...200mg....for a short period. Gradual increase in dosage is also helpful. It would be best not to jump right to the "recommended" dosage of 800mg, as that isn't well tolerated by most patients, and has very pronounced side effects. Most patients find success at 600mg....but go slow in the build up. Some tumor shrinkage may occur but that depends on size and location. The main strength of this medication is the reduction/elimination of tumor blood supply. This may prevent tumor growth. Also, don't expect immediate success. It may take some time for your Dad to adjust to the medication. It should be recommended to avoid alcohol consumption to give the liver a better basis to process the medication. While the listed side effects on many sites look scary, they try to cover all possibilities, and most patients dont experience a fraction of what's listed. Hope this helps your Dad and you in his health journey!! Best wishes!! ❤️

I am dealing with soft tissue sarcoma stage 3, would votrient be an option for me to stop the reacurrance of these tumors. Currently in my lower leg, but they have been reacurring after surgery, now for the third time.

@rogercrumpton - Check with your doctor but this is what I found:

Votrient (pazopanib) is a targeted cancer medication used to treat advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma in adults. It works by blocking specific proteins (tyrosine kinases) involved in tumor growth and blood vessel formation (angiogenesis), including VEGFR, PDGFR, and FGFR.

Key Information:
Mechanism of Action: Votrient is a multi-targeted receptor tyrosine kinase inhibitor that inhibits tumor growth and angiogenesis by blocking key enzymes like VEGFR, PDGFR, and cKIT.
Approved Uses:
First-line treatment for advanced renal cell carcinoma (RCC).
Treatment of advanced soft tissue sarcoma in patients previously treated with chemotherapy.

@laurauhl thank you, I will talk with my team doctor there at Mayo

@laurauhl did your dad start Votrient (pazopanib)? How is he doing on it?

@colleenyoung
Not yet, we have 1 more MD appointment to decide the final plan.